Tag: Prescription Drugs

Cefepime/enmetazobactam is noninferior and superior to piperacillin/tazobactam for clinical cure and microbial eradication

Results of phase 2 study suggest clinical benefit and favorable safety profile, warranting further study of lenabasum for DM

U.S. health officials say it is only coincidental that the order of Nplate comes just as Russia is making nuclear threats

Six-minute walk distance not improved with telmisartan versus placebo in patients with lower-extremity peripheral arterial disease

More pediatric patients free of new or newly enlarging T2 lesions at week 96 with dimethyl fumarate versus interferon beta-1a

Phase 2 trial terminated early, underpowered to meet primary end point, but limited results suggest pirfenidone may slow progression of RA-ILD

5 to 6 percent decrease seen in subcutaneous and visceral adiposity at week 16 of treatment, which was maintained at 52 weeks

Probability of minimal MG manifestations greater, need for rescue medications reduced with rituximab versus placebo

Compared with metformin, SGLT2 inhibitors, GLP-1 receptor agonists cost more for treatment in drug-naive patients with type 2 diabetes

No association seen between estimated R&D investments and treatment costs based on list prices at launch or net prices after one year